592 related articles for article (PubMed ID: 9259327)
1. Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes.
Lazennec G; Ediger TR; Petz LN; Nardulli AM; Katzenellenbogen BS
Mol Endocrinol; 1997 Aug; 11(9):1375-86. PubMed ID: 9259327
[TBL] [Abstract][Full Text] [Related]
2. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein.
Weis KE; Ekena K; Thomas JA; Lazennec G; Katzenellenbogen BS
Mol Endocrinol; 1996 Nov; 10(11):1388-98. PubMed ID: 8923465
[TBL] [Abstract][Full Text] [Related]
3. Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells.
Bai Y; Giguére V
Mol Endocrinol; 2003 Apr; 17(4):589-99. PubMed ID: 12554772
[TBL] [Abstract][Full Text] [Related]
4. Titration by estrogen receptor activation function-2 of targets that are downstream from coactivators.
Lopez GN; Webb P; Shinsako JH; Baxter JD; Greene GL; Kushner PJ
Mol Endocrinol; 1999 Jun; 13(6):897-909. PubMed ID: 10379889
[TBL] [Abstract][Full Text] [Related]
5. Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: evidence that an open pocket conformation is required for ligand interaction.
Carlson KE; Choi I; Gee A; Katzenellenbogen BS; Katzenellenbogen JA
Biochemistry; 1997 Dec; 36(48):14897-905. PubMed ID: 9398213
[TBL] [Abstract][Full Text] [Related]
6. Different classes of coactivators recognize distinct but overlapping binding sites on the estrogen receptor ligand binding domain.
Eng FC; Barsalou A; Akutsu N; Mercier I; Zechel C; Mader S; White JH
J Biol Chem; 1998 Oct; 273(43):28371-7. PubMed ID: 9774463
[TBL] [Abstract][Full Text] [Related]
7. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J
J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597
[TBL] [Abstract][Full Text] [Related]
8. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.
Dutertre M; Smith CL
Mol Endocrinol; 2003 Jul; 17(7):1296-314. PubMed ID: 12714702
[TBL] [Abstract][Full Text] [Related]
9. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS
J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875
[TBL] [Abstract][Full Text] [Related]
10. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL
Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586
[TBL] [Abstract][Full Text] [Related]
11. Identification of charged residues in an N-terminal portion of the hormone-binding domain of the human estrogen receptor important in transcriptional activity of the receptor.
Pakdel F; Reese JC; Katzenellenbogen BS
Mol Endocrinol; 1993 Nov; 7(11):1408-17. PubMed ID: 8114756
[TBL] [Abstract][Full Text] [Related]
12. Regulation of estrogen receptor activation of the prolactin enhancer/promoter by antagonistic activation function-2-interacting proteins.
Schaufele F
Mol Endocrinol; 1999 Jun; 13(6):935-45. PubMed ID: 10379892
[TBL] [Abstract][Full Text] [Related]
13. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA
Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784
[TBL] [Abstract][Full Text] [Related]
14. Effect of ligand and DNA binding on the interaction between human transcription intermediary factor 1alpha and estrogen receptors.
Thénot S; Bonnet S; Boulahtouf A; Margeat E; Royer CA; Borgna JL; Cavaillès V
Mol Endocrinol; 1999 Dec; 13(12):2137-50. PubMed ID: 10598587
[TBL] [Abstract][Full Text] [Related]
15. Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains.
Métivier R; Penot G; Flouriot G; Pakdel F
Mol Endocrinol; 2001 Nov; 15(11):1953-70. PubMed ID: 11682626
[TBL] [Abstract][Full Text] [Related]
16. The Src kinase pathway promotes tamoxifen agonist action in Ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor (alpha) promoter interaction and elevated steroid receptor coactivator 1 activity.
Shah YM; Rowan BG
Mol Endocrinol; 2005 Mar; 19(3):732-48. PubMed ID: 15528270
[TBL] [Abstract][Full Text] [Related]
17. Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements.
Hall JM; McDonnell DP; Korach KS
Mol Endocrinol; 2002 Mar; 16(3):469-86. PubMed ID: 11875105
[TBL] [Abstract][Full Text] [Related]
18. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
[TBL] [Abstract][Full Text] [Related]
19. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members.
Kraichely DM; Sun J; Katzenellenbogen JA; Katzenellenbogen BS
Endocrinology; 2000 Oct; 141(10):3534-45. PubMed ID: 11014206
[TBL] [Abstract][Full Text] [Related]
20. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
MacGregor Schafer J; Liu H; Bentrem DJ; Zapf JW; Jordan VC
Cancer Res; 2000 Sep; 60(18):5097-105. PubMed ID: 11016635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]